CRP and neoplasm: Recent studies have reported the independent association between tumor relapse and elevation of serum inflammatory biomarkers, including C-reactive protein (CRP), interleukin-6, and serum amyloid A; this suggests that systemic inflammation affects breast cancer recurrence2.